Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 1, keine Gesamtzahl für „avoided“
Suchtreffer
Begriffe & Kennungen
Akeega · 4.5 · 9 wort [Hypericum perforatum]) during treatment with Akeega should be avoided unless there is no therapeutic a
Eintrag öffnenAzilect · 4.5 · The concomitant use of rasagiline and fluoxetine or fluvoxamine should be avoided (see section 4.4).
Eintrag öffnenBalversa · 4.5 · Grapefruit or Seville oranges should be avoided while taking Balversa due to strong CYP3A4 inhibition (see sec
Eintrag öffnenBeromun · 4.5 · Combinations with cardiotoxic substances (e.g. anthracyclines) should be avoided because it is possible that t
Eintrag öffnenCalquence · 4.5 · Concomitant use with strong CYP3A/P-gp inhibitors should be avoided. If the strong CYP3A/P-gp inhibitors (e.g.
Eintrag öffnenCalquence · 4.5 · Concomitant use with strong CYP3A/P-gp inhibitors should be avoided. If the strong CYP3A/P-gp inhibitors (e.g.
Eintrag öffnenCeplene · 4.5 · Tricyclic anti-depressants may have H1 and H2 receptor blocking properties and should be avoided.
Eintrag öffnenCholib · 4.5 · Concomitant use of simvastatin with ribociclib should be avoided.
Eintrag öffnenCholib · 4.5 · Concomitant use of simvastatin with ribociclib should be avoided.
Eintrag öffnenDeferasirox Accord · 4.5 · 11 deferasirox with repaglinide should be avoided. If the combination appears necessary, careful clinical and
Eintrag öffnenDiacomit · 4.5 · 16 Undesirable combinations (to be avoided unless strictly necessary) - Rye ergot alkaloids (ergotamine, dihyd
Eintrag öffnenDiacomit · 4.5 · 27 Undesirable combinations (to be avoided unless strictly necessary) - Rye ergot alkaloids (ergotamine, dihyd
Eintrag öffnenDiacomit · 4.5 · 38 Undesirable combinations (to be avoided unless strictly necessary) - Rye ergot alkaloids (ergotamine, dihyd
Eintrag öffnenDiacomit · 4.5 · 5 Undesirable combinations (to be avoided unless strictly necessary) - Rye ergot alkaloids (ergotamine, dihydr
Eintrag öffnenDiacomit · 4.5 · Co-administration with CYP3A4 substrates with a narrow therapeutic index should be avoided due to the markedly
Eintrag öffnenDiacomit · 4.5 · Co-administration with CYP3A4 substrates with a narrow therapeutic index should be avoided due to the markedly
Eintrag öffnenDiacomit · 4.5 · Co-administration with CYP3A4 substrates with a narrow therapeutic index should be avoided due to the markedly
Eintrag öffnenDiacomit · 4.5 · Co-administration with CYP3A4 substrates with a narrow therapeutic index should be avoided due to the markedly
Eintrag öffnenDukoral · 4.5 · Oral administration of other vaccines and medicinal products should be avoided 1 hour before and 1 hour after
Eintrag öffnenEmtricitabine/Tenofovir disoproxil Krka · 4.5 · Use of Emtricitabine/Tenofovir disoproxil Krka should be avoided with concurrent or recent use of a nephrotoxi
Eintrag öffnen